Valuation: Illumina, Inc.

Capitalization 14.49B 12.46B 11.65B 10.63B 19.85B 1,245B 22.25B 138B 53B 574B 54.35B 53.21B 2,097B P/E ratio 2025 *
26x
P/E ratio 2026 * 22.5x
Enterprise value 14.1B 12.13B 11.35B 10.35B 19.32B 1,212B 21.66B 134B 51.59B 559B 52.9B 51.79B 2,041B EV / Sales 2025 *
3.33x
EV / Sales 2026 * 3.04x
Free-Float
79.72%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.00%
1 week+2.29%
Current month+11.28%
1 month+13.87%
3 months+3.98%
6 months-32.31%
Current year-31.51%
More quotes
1 week 88.68
Extreme 88.675
91.66
1 month 78.79
Extreme 78.79
91.66
Current year 68.7
Extreme 68.7
153.06
1 year 68.7
Extreme 68.7
156.66
3 years 68.7
Extreme 68.7
248.87
5 years 68.7
Extreme 68.7
555.77
10 years 68.7
Extreme 68.7
555.77
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2023-09-24
Director of Finance/CFO 49 2024-04-14
Chief Tech/Sci/R&D Officer - 2023-08-08
Director TitleAgeSince
Director/Board Member 70 2012-11-28
Director/Board Member 68 2016-01-27
Director/Board Member 64 2016-07-27
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.00%+2.29%-16.98%-52.81% 14.49B
+1.55%+2.14%+21.92%+149.48% 187B
+1.72%+2.35%+35.73%+173.86% 154B
+1.04%+3.62%-28.55%-25.78% 153B
+0.58%+0.88%-23.09%-23.11% 141B
+0.75%+2.25%-12.34%+0.15% 60.8B
+0.70%+3.52%-15.88%-21.79% 44.49B
-0.44%-3.09%-23.87%-29.58% 37.92B
+0.55%+2.33%+40.46%+21.00% 37.46B
+1.30%+1.34%-12.91%-3.01% 33.42B
Average +0.80%+0.44%-3.55%+18.84% 86.41B
Weighted average by Cap. +1.04%-0.20%+0.54%+52.59%
See all sector performances

Financials

2025 *2026 *
Net sales 4.23B 3.64B 3.41B 3.11B 5.8B 364B 6.5B 40.3B 15.49B 168B 15.88B 15.55B 613B 4.39B 3.78B 3.53B 3.22B 6.02B 378B 6.75B 41.84B 16.07B 174B 16.48B 16.14B 636B
Net income 552M 475M 444M 405M 756M 47.44B 848M 5.26B 2.02B 21.86B 2.07B 2.03B 79.89B 628M 540M 505M 461M 860M 53.96B 964M 5.98B 2.3B 24.86B 2.36B 2.31B 90.86B
Net Debt -385M -331M -310M -283M -528M -33.11B -592M -3.67B -1.41B -15.26B -1.45B -1.41B -55.75B -1.11B -955M -893M -815M -1.52B -95.46B -1.71B -10.57B -4.06B -43.98B -4.17B -4.08B -161B
More financial data * Estimated data
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
9,000
More about the company
Date Price Change Volume
25-06-24 91.52 $ +1.00% 2,323,504
25-06-23 90.61 $ +0.13% 2,151,048
25-06-20 90.49 $ +0.25% 3,182,240
25-06-18 90.26 $ +0.88% 2,028,519
25-06-17 89.47 $ -0.86% 2,387,287

Delayed Quote Nasdaq, June 24, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
91.52USD
Average target price
108.48USD
Spread / Average Target
+18.53%
Consensus

Quarterly revenue - Rate of surprise